Table 1. Demographics, clinical characteristics of the Chinese renal transplant recipients.

	Days 1 to 3	Days 6 to 8	Days 12 to 14	Stable condition
	n = 240	n = 240	n = 240	n = 183
Age (years), (mean ± SD)	41.03±12.22	41.03±12.22	41.03±12.22	41.77±12.14
Gender (male/female)	161/79	161/79	161/79	124/59
Body weight (kg) (mean ± SD)	57.94±10.12	57.94±10.12	57.94±10.12	58.25±10.18
Hematocrit (%)	0.353±0.0559	0.339±0.0577	0.303±0.0496	0.309±0.0413
Hemoglobin (g/L)	115.2±19.8	112.8±18.8	100.8±16.4	101.2±14.0
Albumin (g/L)	35.3±4.5	35.9±4.9	37.0±5.3	38.6±4.5
Alanine aminotransferase (ALT), (U/L)	18.0±14.0	27.9±35.6	40.6±45.4	29.7±31.2
Aspartate aminotransferase(AST), (U/L)	19.3±11.6	22.2±16.4	22.5±14.0	17.7±9.0
Total bilirubin (TBIL), (μmol/L)	10.22±4.43	11.19±4.57	9.21±3.70	8.99±3.31
Unconjugated bilirubin(IBIL), (μmol/L)	7.12±3.15	7.80±3.34	6.24±2.69	6.08±2.55
Tacrolimus dose (mg/day)	6.64±1.56	7.02±2.16	7.88±2.97	8.30±3.15
Tacrolimus concentration (ng/ml)	10.8±5.4	10.3±4.0	10.1±3.5	11.0±1.3
Concentration/Dose Ratio (ng/ml)/(mg/kg)	95.5±49.1	95.7±57.0	86.3±52.7	90.8±47.1